Latest Health News

Acrux Limited’s FY26 receipts soared 960% to $5 million, fuelled by licensing milestones and growing generic sales, while FDA guidance clears the way for pivotal Phase III trials of its Female Testosterone therapy.

Emerald Resources NL sustained steady gold output at its Okvau Mine with 27.1Koz produced in June quarter while progressing the Dingo Range Gold Project towards production, supported by a robust cash position of A$481 million.

Skin Elements has secured an exclusive New Zealand distribution agreement for its ECO-Nurture bio-stimulant, raised $1.47 million through options and placement, and refreshed its board after shareholder votes.

Finder Energy has secured key regulatory approval for its KTJ Project in Timor-Leste and raised $27 million to advance development, positioning for a Final Investment Decision in Q3 2026.

PLC Resources has completed its first RC drilling at Rochefort, revealing anomalous gold and identifying a new structural corridor at Abbotts North. The company also raised $1.8 million to fund exploration at its Yalgoo and Abbotts North projects.

Lac Gold Limited's latest drilling at the Rouyn Gold Project reveals extensive high-grade gold mineralisation, while the acquisition of the historic Golden Patricia Mine adds a significant growth platform. The company ends the quarter with $13.3 million in cash and a clear focus on resource expansion.

Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.

EBR Systems advanced its wireless cardiac pacing rollout in Q2 2026, completing 46 implants and signing 17 new purchasing contracts while shifting focus to deeper utilisation within existing accounts.

Hot Chili Limited is accelerating development at its La Verde copper-gold deposit in Chile, reporting strong drilling results and securing an additional US$15 million via an amended royalty agreement with OR Royalties. The company is progressing environmental assessments and pre-feasibility studies for the broader Costa Fuego project while maintaining a robust cash position.

HITIQ Limited has fortified its financial position through a $1.4 million placement and secured milestone-based Victorian Government funding, accelerating its manufacturing expansion and commercial growth in concussion management technology.

Rhythm Biosciences bolstered its financial position with a $5.2 million option underwriting while accelerating commercial adoption of its ColoSTAT® colorectal cancer test and advancing geneType™ partnerships internationally in Q4 FY26.

Audeara Ltd posted record FY26 cash receipts of $4.2 million and unaudited revenue of $4.44 million, driven by progress in AI audio licensing, exclusive assistive listening deals, and a large-scale Auracast deployment across retirement villages.